Data updated: Mar 10, 2026
HALOBETASOL PROPIONATE
HALOBETASOL PROPIONATE
Approved 2004-12-16
9
Indications
--
Phase 3 Trials
21
Years on Market
Details
- Status
- None (Tentative Approval)
- First Approved
- 2004-12-16
- Routes
- UNKNOWN, TOPICAL
- Dosage Forms
- UNKNOWN, OINTMENT, CREAM, AEROSOL, FOAM, LOTION
HALOBETASOL PROPIONATE Approval History
Loading approval history...
What HALOBETASOL PROPIONATE Treats
9 FDA approvalsOriginally approved for its first indication in 2004 . Covers 9 distinct patient populations.
- Other (9)
Other
(9 approvals)- • Approved indication (Dec 2004)Letter
- • Approved indication (Jun 2005)
- • Approved indication (Aug 2005)
- • Approved indication (Sep 2006)
- • Approved indication (Apr 2007)
- • Approved indication (Mar 2018)
- • Approved indication (Jun 2020)Letter
- • Approved indication (Oct 2020)
- • Approved indication (Aug 2023)Letter
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
HALOBETASOL PROPIONATE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.